Schedule 13G ownership disclosure
BIONDVAX PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 09073Q105
Event date: 2022-09-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001567619-22-018298
- Form type
- SC 13G
- Filer
- Scinai Immunotherapeutics Ltd.
- CIK
- CIK 1611747
- Filed
- Oct 06, 2022
- Reporting period
- Sep 19, 2022
- Description
- Schedule 13G beneficial ownership